Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2023-09-29 00:00:00 ET · period of report 2023-09-27 · accession 0001493152-23-034857 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-29 | 2023-09-27 | ABEO | Charles Faith L. | Dir | S - Sale | $4.91 | -8,330 | 70.8K | -11% | -$40.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-27 | S | D | 8,330 | $4.91 | 70,773 | D | — | — | (F2) Weighted average price. These shares were sold in multiple transactions at prices ranging from $3.8200 to $4.2100 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |